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Learning objectives
1. To demonstrate the merit of each imaging technique in the evaluation of
metastatic spread of melanoma.
2. To discuss the potential patterns and location of distant dissemination of
melanoma.
Background
Primary melanoma
Definition:
-Aggressive tumor originating from melanocytes.
Epidemiology:
-2,2-19,2/100 000 in Europe
-1,5/100 000 mortality rate
Risk factors:
• White race
• Sun sensitivity
• Severe sunburns
• Many moles
• Freckles
• Family history of skin cancer
Primary Melanoma workout:
-Breslow and Clark for staging primary lesion
-TNM classification:
• Breslow thickness
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• Clark level
• Locoregional metastasis
• Distant metastasis
• Serum LDH is an independent prognostic factor aside from the location of
metastasis
-Poor prognosis for advanced disease
Disease staging is performed using the TNM classification on a clinical or pathological
base (Table 1 on page 4).
Imaging plays a pivotal role in the staging, follow-up and monitoring of treatment response
of malignant melanoma.
The purpose of this poster is to evaluate the potential patterns and location of distant
dissemination and the merit of each imaging technique in the evaluation of metastatic
spread.
Metastatic melanoma
Definition:
Metastatic melanoma is tumor spread beyond the primary lesion. Tumor dissemination
occurs through lymphatic or hematogenous spread Fig. 1 on page 4. Metastasis
is subdivided in locoregional metastasis Fig. 2 on page 5 or distant metastasis.
Locoregional metastasis mainly occurs through lymphatic spread.
Locoregional metastasis:
• Local recurrences
• Satellite metastasis Fig. 3 on page 6
• In-transit metastasis Fig. 4 on page 7
• Nodal basin
Distant metastasis are classified in 3 groups, according to the side of metastasis
and serum LDH:
• M1a: Metastasis to distant skin, subcutaneous tissue or distant lymph nodes
with a normal serum LDH
• M1b: Metastasis to the lung with a normal serum LDH
• M1c: Metastasis to any other viceral organ with a normal serum LDH or with
any metastasis with an elevated serum LDH
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Images for this section:
Table 1: Table of the clinical and pathologic TNM classification. Further discussion is
beyond the scope of this poster. Further down this poster, we will point out when imaging
for metastatic melanoma is indicated in asymptomatic patients.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 1: Schematic drawing of hematogenous and lymphatic dissemination.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 2: Schematic drawing of locoregional metastasis.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 3: Schematic drawing of locoregional metastasis. Satellite metastasis (red) are
cutaneneous or subcutaneous metastasis located between the primary lesion or scar
tissue and the draining lymph node basin. They are located within 2 cm from the primary
tumor or scar tissue. Satellite metastasis are considered a nodal metastasis in the TNM
classification.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 4: Schematic drawing of in-transit metastasis. In-transit metastasis (red) are
cutaneous or subcutaneous metastasis located between the primary lesion or scar tissue
and the draining lymph node basin. They are 2 cm away from the primary tumor or scar
and before reaching the regional lymph node basin. In-transit metastasis are considered
a nodal metastasis in the TNM classification.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Findings and procedure details
I. MERIT OF EACH IMAGING TECHNIQUE IN THE EVALUATION OF METASTATIC
SPREAD OF MELANOMA
1. General need for imaging
2. Ultrasound
3. Radiography
4. Computed tomography
5. Magnetic resonance imaging
6. Lymphoscintigraphy
7. Positron emission tomography - computed tomography
II. POTENTIAL PATTERNS AND LOCATION OF DISTANT DISSEMINATION OF
MELANOMA
1. Locoregional metastasis
2. Chest
3. Central nervous system
4. Abdomen
5. Musculoskeletal system
6. Miscellaneous
I. MERIT OF EACH IMAGING TECHNIQUE IN THE EVALUATION OF METASTATIC
SPREAD OF MELANOMA
1. General need for imaging
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Table 2
References: Department of Radiology, University Hospital Antwerp - Antwerp/BE
2. Ultrasound
-Advantages:
• Cheap
• Primary melanoma
• Evaluation of local recurrence, in-transit or regional lymph nodes metastases
Fig. 5 on page 17
• Fine needle aspiration cytology (FNAC) Fig. 6 on page 18 :
-In-transit and satellite: 95% sensitivity and 100% specificity
-Nodal basins: 79% sensitivity and 100% specificity
-Disadvantages:
• Limited use for distant metastasis
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-Imaging characterization:
• Hypo-echoic Fig. 7 on page 19
• Hypervascularisation on power doppler Fig. 8 on page 20
3. Radiography
-Advantages:
• Cheap
• Low radiation dose
• Chest x-ray for baseline comparison Fig. 9 on page 21
-Disadvantages:
• Low sensitivity and specificity
-Bone metastasis only visible when cortical destruction or
#30% trabecular bone loss occurs Fig. 10 on page 22
• Limited role in staging/evaluation of metastatic melanoma
-Imaging characterization:
• Hilar enlargement Fig. 11 on page 22
• Lung nodules or masses Fig. 9 on page 21
• Bone metastasis are generally osteolytic Fig. 10 on page 22
4. Computed tomography
-Advantages:
• Quick examination of large body parts
• Widespread availability
• Different windowing settings for the evaluation of bone and different organ
systems on one examination Fig. 12 on page 23
• Best technique detecting lung metastasis
• Monitoring treatment outcome: CT + serum LDH à predicting survival
-Disadvantages:
• Radiation dose
• Not the highest sensitivity and specificity in most organ systems
-Imaging characterization:
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• Hypervascular metastasis
-Enhancing on peak hepatic arterial phase Fig. 13 on page 24
-Heterogeneous, rim or nodular enhancement
• Hepatic metastasis
-Multiphase CE CT with at least 2 different phases Fig. 14 on page 25
• Intratumoral haemorrhage Fig. 15 on page 25
-Non CE CT and CE CT in acute setting
-MRI when available
5. Magnetic resonance imaging
-Advantages:
• Detailed tumor size and preoperative assessment
• Highest sensitivity and specificity in most organ systems, except for lung
metastasis
• Characterization questionable lesions
• Whole-body MRI promising technique
-Disadvantages:
• Limited availability
• Limited field of view
• Patient-related contraindications
-MRI characterization:
• Paramagnetic effect of melanin with typical signal on T1- and T2-WI Fig. 16
on page 26
-Hyperintense on T1-WI
-Hypointense on T2-WI
• Melanotic metastasis comprise 25 % of lesions: >10% melanin cells
• Amelanotic metastasis with non specific signal intensity Fig. 17 on page 27
• Hypervascular metastasis with contrast behavior similar to CT Fig. 18 on page
28 Fig. 19 on page 28
• Intratumoral haemorrhage in 19% of brain metastasis Fig. 29 on page 36
Fig. 30 on page 37
-Acute, subacute and chronic bleeding
6. Lymphoscintigraphy
• Sentinel node is the first lymph node or group of lymph nodes, draining the
tumor
• Radioactive tracer
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• Primary staging
• Considered in stage IA
• Should be performed in stage IB and II
7. Positron emission tomography - computed tomography
-Advantages:
• Metabolic function and high anatomic resolution Fig. 20 on page 30
• High specificity and sensitivity
• Characterization of indeterminate lesions Fig. 21 on page 30
• Exact staging for patients with resectable distant metastasis
-Disadvantages:
• Expensive
• High radiation dose
• Limited availability
-PET alone has a poor anatomic resolution and low specificity and is not routinely
used in metastatic melanoma
II. POTENTIAL PATTERNS AND LOCATION OF DISTANT DISSEMINATION OF
MELANOMA
Metastatic pattern of malignant melanoma
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Table 3
References: Department of Radiology, University Hospital Antwerp - Antwerp/BE
1. Locoregional metastasis
-Clinical examination
-US and subsequent FNAC if indicated
-CT and MRI not routinely used
-Locations:
• Local recurrences
• Satellite metastasis Fig. 23 on page 32
• In-transit metastasis Fig. 23 on page 32
• Nodal basin
2. Chest
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-CT modality of choice
-Lung is most affected visceral organ (36%)
-Most lesions measure 1-2 cm
-Feeding vessel as sign of hematogenous spread
-Location:
• Lung parenchyma
• Pleura
• Mediastinal and hilar lymph nodes
Fig. 24 on page 32
3. Central nervous system
-MRI modality of choice
-Acute haemorrhagic brain metastasis: CT and CE CT Fig. 29 on page 36 Fig.
30 on page 37
-Locations:
• Brain: 20%
-Intra-axial Fig. 25 on page 33 Fig. 26 on page 34
-Leptomeningeal Fig. 27 on page 35 Fig. 28 on page 36
• Spinal:
-Intramedullary
-Leptomeningeal Fig. 31 on page 38
-Epidural Fig. 17 on page 27
4. Abdomen
-Multiphasic CE CT Fig. 14 on page 25
-MRI for questionable lesions
-Locations:
• Liver: 20%
-Variable in size, up to 15 cm.
-Intralesional hemorrhage, calcifications and necrotic areas Fig. 32 on page
38
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• Adrenal glands, usually unilateral Fig. 33 on page 39
• Gastrointenstinal tract: small bowel > colon > stomach Fig. 34 on page
39
• Duodenum, rectum, esophagus and anus infrequent Fig. 35 on page 40
• Spleen unfrequent Fig. 36 on page 40
• Kidney, pancreas Fig. 37 on page 41 and gallbladder Fig. 38 on page
42 rare
• Lymph nodes Fig. 39 on page 43
5. Musculoskeletal system
-CT for bone
-PET/CT or MRI for questionable lesions Fig. 21 on page 30
-MRI for muscle
-Osteolytic, slightly expansile lesions Fig. 10 on page 22
-Rarely isolated muscle involvement
-Location:
• Bone: 17%
-Axial skeleton
-Ribs
-Others Fig. 40 on page 43
• Muscles:
-Lower extremities > trunk > upper extremities Fig. 23 on page 32
6. Miscellaneous
• Although cardiac Fig. 12 on page 23 and breast metastasis is rare, the
prevalence is higher in melanoma compared to other tumors Fig. 41 on page
43
• Salivary glands is extremely rare Fig. 41 on page 43
• Primary melanoma of the eye and paranasal sinuses is known. Metastasis
should be considered in disseminated disease, but metachronous tumor
should always be considered
Images for this section:
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Table 2
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Fig. 5: Schematic drawing (A) of locoregional metastasis indicating the primary
lesion, satellite metastasis, in-transit metastasis and metastasis to the nodal basin. An
anatomical correlation with US (B), CT (C) and MRI (D) of the upper leg. The blue arrow
indicates the transition between cutis and subcutis. US has a higher anatomical resolution
of the cutis and subcutis than CT and MRI. Unfortunately, US is limited by its poor deep
penetration.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 6: US guided FNAC shows the needle (red arrow) in a hypo-echoic lesions.
Histopathology confirmed metastatic melanoma.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 7: Grey-scale US (A) of the left upper leg shows multiple hypoechoic lesions located
in the sartorius muscle. The lesion indicated by the blue arrow is a satellite metastasis and
the red arrow indicates an in-transit metastasis. The yellow line demarcates the difference
between satellite and in-transit metastasis. The lesions have a cable-like appearance,
initially interpreted as a neurogenic tumor. The lesions show increased vascularity on
power doppler US (B).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 8: Grey-scale US (A) of the left upper leg shows multiple hypoechoic lesions located
in the sartorius muscle. The lesion indicated by the blue arrow is a satellite metastasis and
the red arrow indicates an in-transit metastasis. The yellow line demarcates the difference
between satellite and in-transit metastasis. The lesions have a cable-like appearance,
initially interpreted as a neurogenic tumor. The lesions show increased vascularity on
power doppler US (B).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 9: A baseline X-ray of the chest (A), helps to detect small lung metastasis (red arrow)
in the right lung and the pleural effusion in the left lung (blue arrow).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 10: Plain radiograph (A) shows destruction of the cortical outline of the pedicle of
Th11 (red circle). CT (B) confirms a osteolytic metastasis with soft tissue component
expanding in the spinal cord (red arrow).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 11: PA chest X-ray (A) shows an enlarged right hilum (red arrow), suspicious for
adenopathy which was confirmed on CE CT (B) (red arrows).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 12: Axial CE CT Chest. A, mediastinal window settings, shows a mass in the
interventricular septum. Adjusting the window settings (B and C), allows a better
visualisation of the mass.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 13: CE CT arterial phase (A) and portovenous phase (B): A shows a lesion with
enhancement in the arterial phase (black arrow) and washout in the portovenous phase.
Two other lesions (red arrows) show peripheral rim enhancement in the arterial phase.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 14: Axial CT of the abdomen. Non-CE CT (A) shows multiple low attenuating liver
masses. CE CT in the arterial phase (B and C), shows heterogeneous enhancement of
a lesion (red arrow) as well as rim enhancement (blue arrow). CE CT in the portovenous
phase (D), shows no washout.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 15: Non CE CT shows a haemorrhagic lesion (red arrow) with peripheral edema
(green arrows).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 16: An illustration of the specific behavior of metastatic melanoma within the brain on
T1- and T2-WI. T2-WI (A) shows hypointense cortical nodules in the left frontal lobe and
in the right temporal lobe (red arrows). The same lesions are hyperintense on T1-WI (B).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 17: T2-WI (A) and T1-WI (B) shows a lesion isointense to muscle posterior in
the spinal canal , located in the epidural space (red arrow). T1-WI after gadolinium
administration (C) shows marked enhancement. This is an example of metastatic
melanoma with nonspecific signal characterization.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 18: T1 WI shows a spontaneous hyperintense leptomeningeal metastasis at the left
Sylvian fissure. After gadolinium administration, there is a marked enhancement on T1
WI + Gd (B) and subtraction images (C).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 19: An illustration of the specific behavior of metastatic melanoma within the brain
on T1- and T2-WI. T2-WI (A) shows hypointense cortical nodules in the left frontal lobe
and in the right temporal lobe (red arrows). The lesions are hyperintense on T1-WI (B).
After administration of Gd contrast (C), there is marked enhancement seen on T1-WI and
on the T1-WI subtraction images(D).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 20: Fusion PET/CT shows marked tracer hypercaptation in various locations in
keeping with metastasis.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 21: Axial CT shows questionable lytic lesions in the right femoral neck (A) and in
the thoracic spine (C). Fusion PET/CT (B and D) confirms metabolic activation, in this
patient, in keeping with metastatic melanoma.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 22: CE CT of the abdomen (A) shows an enhancing subcutaneous metastasis
located in the right gluteal region (white arrow). Follow-up CE CT (B) shows a marked
enlargement of the lesions (white arrow).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 23: Grey-scale US of the right upper leg (A) shows one satellite (blue arrow) and
multiple in-transit metastases (red arrow) located in the sartorius muscle. Axial T1-WI
with fs (B) and sagittal T1 WI (C) shows a spontaneous hyperintense nodular lesion in
the sartorius muscle.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 24: CE CT of the chest of different patients shows mediastinal lymph node (A),
pleural (B), multiple pulmonary (C) metastases. Illustration of feeding vessels (blue
arrows), in keeping with hematogenous spread (D).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 25: Axial T1-WI after gd shows a cortical lesion in the frontal lobe (A) and a nodular
leptomeningeal lesion posterior of the sylvian fissure (B).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 26: Axial T1-WI (A) shows a spontaneous hyperintense lesion in the right
hypocampus. Saggital (B) and coronal (C) T1-WI + gd clearly demonstrates the
hippocampal localization.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 27: T1 WI shows a spontaneous hyperintense leptomeningeal metastasis at the left
Sylvian fissure. After gadolinium administration, there is a marked enhancement on T1
WI + Gd (B) and subtraction images (C).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 28: Axial T1-WI before (A) and after administration of gadolinium (B) shows a diffuse
enhancement (green arrows) of the leptomeninges of the right temporal lobe, which is
clearly visible on the T1-WI subtraction images(C).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 29: CT and MRI of an acute intratumoral haemorrhage. Non-CE CT (A) shows a
heterogeneous hyperdense lesion with associated haemorrhage and marked perilesional
edema. T2-WI (B) confirms as a hypo- to isointense lesion with hyperintense surrounding
edema. The haemorrhage is hypointense.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 30: T1-WI (C) shows a hypointense lesion with a peripheral hyperintense rim.
The haemorrhage is hypo- to isointense. T1-WI after administration of gadolinium (D)
shows heterogeneous and peripheral rim enhancement of the nodule and peripheral rim
enhancement of the haemorrhage which is clearly seen on T1-WI subtraction images (E).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 31: T2-WI (A) shows an isointense leptomeningeal metastasis (red arrow) in the
spinal cord, located at the cauda equina. Sagittal (B) and axial (A) contrast-enhanced
T1-WI shows a marked enhancement (red arrow).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 32: Axial (A) and coronal (B) CE CT of the abdomen. A and B shows a large
heterogeneous enhancing lesion in the liver. The lesion contains hypodense regions with
no contrast enhancement in keeping with necrotic areas. The red circle indicates a large
necrotic area. This patient had diffuse metastases with one large liver lesion. Mark the
small metastasis in the spleen (green arrow).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 33: Axial (A) and coronal (B) CE CT shows a metastasis in the left adrenal gland
(red arrow).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 34: Axial CE CT after administration of oral contrast shows small bowel metastasis.
A shows a diffuse thickening of the jejunal wall (red arrows) and B shows multiple focal
thickening of ileal bowel loops (red arrows).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 35: Axial CE CT after administration of oral contrast shows an example of metastatic
melanoma involving the rectum.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 36: T1-WI (A) shows a mass (red arrow) isointense to muscle in the spleen. On
T2-WI (B) the mass has regions of iso- and hyperintensity. T1-WI after administration of
gadolinium contrast (C) shows a heterogeneous enhancement of the mass.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 37: Axial CT and MRI of the pancreas. CE CT (A) shows a heterogeneous enhancing
mass in the pancreas. T1-WI (B) with FS shows a heterogeneous mass with regions of
high and low intensity in the pancreas. The mass is hyperintense on T2-WI with FS (C).
DWI (D) and ADC (not shown) shows marked diffusion restriction.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 38: Axial CE CT shows a heterogeneous enhancing mass in the gallbladder (white
arrow). Fusion PET/CT shows a high metabolic activity in this lesion (white arrow). After
surgical resection, histopathology showed a metastatic melanoma in the gallbladder.
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 39: Axial CE CT A and B shows multiple slightly enlarged lymph nodes located
mesentery and retroperitoneal (red arrows).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
Fig. 40: CT of the chest shows an osteolytic metastasis with soft tissue component in
the fourth left rib (A) and scapula (B).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Fig. 41: CE CT shows a mass in the left submandibular gland (A), right breast (B) and
heart (C).
© Department of Radiology, University Hospital Antwerp - Antwerp/BE
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Conclusion
• The most frequent locations of metastasis are locoregional, lung,
brain, liver or bones.
• US is used for superficial located lymphogenic spread for easily
accessible areas. US is generally not used for hematogenous spread
or deep locations.
• CT and PET/CT are the most used imaging modalities to evaluate
hematogenous metastasis on most locations.
• MR is most sensitive and specific except for lung disease.
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